Details for New Drug Application (NDA): 021712
✉ Email this page to a colleague
The generic ingredient in FLUXID is famotidine. There are eighteen drug master file entries for this compound. One hundred and forty-four suppliers are listed for this compound. Additional details are available on the famotidine profile page.
Summary for 021712
Tradename: | FLUXID |
Applicant: | Ucb Inc |
Ingredient: | famotidine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021712
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 20MG | ||||
Approval Date: | Sep 24, 2004 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 40MG | ||||
Approval Date: | Sep 24, 2004 | TE: | RLD: | No |
Expired US Patents for NDA 021712
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ucb Inc | FLUXID | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 021712-001 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Ucb Inc | FLUXID | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 021712-002 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Ucb Inc | FLUXID | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 021712-002 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Ucb Inc | FLUXID | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 021712-001 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription